Oramed Pharmaceuticals Price to Book Ratio 2011-2024 | ORMP
Historical price to book ratio values for Oramed Pharmaceuticals (ORMP) over the last 10 years. The current price to book ratio for Oramed Pharmaceuticals as of February 27, 2025 is 0.57.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Oramed Pharmaceuticals Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-02-27 | 2.10 | 0.54 | |
| 2024-09-30 | 2.44 | $3.87 | 0.63 |
| 2024-06-30 | 2.57 | $4.34 | 0.59 |
| 2024-03-31 | 2.92 | $4.09 | 0.71 |
| 2023-12-31 | 2.31 | $4.04 | 0.57 |
| 2023-09-30 | 2.61 | $3.68 | 0.71 |
| 2023-06-30 | 3.58 | $3.75 | 0.96 |
| 2023-03-31 | 2.18 | $3.76 | 0.58 |
| 2022-12-31 | 12.03 | $3.82 | 3.15 |
| 2022-09-30 | 6.48 | $3.92 | 1.65 |
| 2022-06-30 | 4.58 | $3.97 | 1.15 |
| 2022-03-31 | 8.65 | $4.21 | 2.06 |
| 2021-12-31 | 14.28 | $4.37 | 3.27 |
| 2021-11-30 | 19.22 | $4.48 | 4.29 |
| 2021-09-30 | 21.98 | 0.00 | |
| 2021-08-31 | 19.68 | 0.00 | |
| 2021-06-30 | 13.38 | 0.00 | |
| 2021-05-31 | 11.52 | $2.27 | 5.08 |
| 2021-03-31 | 10.16 | 0.00 | |
| 2021-02-28 | 8.91 | $1.75 | 5.10 |
| 2020-11-30 | 4.26 | $1.18 | 3.60 |
| 2020-08-31 | 3.49 | 0.00 | |
| 2020-05-31 | 3.14 | $1.47 | 2.14 |
| 2020-02-29 | 4.08 | $0.70 | 5.86 |
| 2019-11-30 | 4.41 | $0.99 | 4.47 |
| 2019-08-31 | 3.32 | 0.00 | |
| 2019-05-31 | 3.00 | $1.24 | 2.42 |
| 2019-02-28 | 3.20 | $1.46 | 2.19 |
| 2018-11-30 | 4.08 | $1.66 | 2.46 |
| 2018-08-31 | 4.95 | 0.00 | |
| 2018-05-31 | 7.91 | $1.15 | 6.87 |
| 2018-02-28 | 7.25 | $1.42 | 5.10 |
| 2017-11-30 | 9.14 | $1.59 | 5.75 |
| 2017-08-31 | 8.65 | 0.00 | |
| 2017-05-31 | 8.15 | $1.49 | 5.48 |
| 2017-02-28 | 6.05 | $1.60 | 3.77 |
| 2016-11-30 | 6.14 | $1.81 | 3.40 |
| 2016-08-31 | 7.21 | 0.00 | |
| 2016-05-31 | 8.72 | $2.36 | 3.70 |
| 2016-02-29 | 7.09 | $2.49 | 2.84 |
| 2015-11-30 | 9.10 | $1.94 | 4.68 |
| 2015-08-31 | 5.62 | 0.00 | |
| 2015-05-31 | 6.66 | $1.97 | 3.38 |
| 2015-02-28 | 4.52 | $2.06 | 2.19 |
| 2014-11-30 | 6.00 | $2.19 | 2.74 |
| 2014-08-31 | 10.14 | 0.00 | |
| 2014-05-31 | 8.33 | $2.21 | 3.77 |
| 2014-02-28 | 14.86 | $2.39 | 6.23 |
| 2013-11-30 | 8.30 | $0.92 | 9.03 |
| 2013-08-31 | 7.29 | 0.00 | |
| 2013-05-31 | 9.18 | $0.58 | 15.95 |
| 2013-02-28 | 9.00 | $0.73 | 12.39 |
| 2012-12-31 | 3.96 | 0.00 | |
| 2012-11-30 | 3.72 | $0.07 | 51.52 |
| 2012-08-31 | 3.84 | 0.00 | |
| 2012-05-31 | 4.08 | $0.03 | 145.71 |
| 2012-02-29 | 3.36 | $0.03 | 98.25 |
| 2011-11-30 | 3.60 | $0.05 | 76.11 |
| 2011-09-30 | 4.20 | 0.00 | |
| 2011-08-31 | 3.48 | 0.00 | |
| 2011-06-30 | 3.48 | 0.00 | |
| 2011-05-31 | 3.96 | 0.00 | |
| 2011-03-31 | 3.24 | 0.00 | |
| 2011-02-28 | 3.72 | 0.00 | |
| 2010-12-31 | 3.60 | 0.00 | |
| 2010-11-30 | 3.72 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.087B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Medtronic (MDT) | Ireland | $115.624B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Insulet (PODD) | United States | $19.908B | 85.13 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
| LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
| Neogen (NEOG) | United States | $2.261B | 26.05 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |